Concepedia

Author

Noushin Saljoughian

The Ohio State University Wexner Medical CenterORCID

Also Known As

N. Saljoughian, Noushin SALJOUGHIAN, Noushin Saljoughian

34

Publications

673

Citations

14

H-Index

33

Concepts

All Affiliations

The Ohio State University Wexner Medical CenterThe Ohio State UniversityPasteur Institute of IranUniversité LavalTehran University of Medical Sciences
NS

About

Noushin Saljoughian is an author at The Ohio State University Wexner Medical Center specializing in medicine, parasitology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

130

2

Immunology

3

3

107

3

Engineering

1

1

50

4

Allergy

1

1

50

5

Biomolecular Engineering

1

1

50

Noushin Saljoughian

×

14

Publications

554

Citations

12

H-Index

YearCitations

A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing

Wen‐Wei Zhang, Subir Karmakar, Sreenivas Gannavaram,

Nature Communications

2020

113

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis

Noushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard,

PLoS neglected tropical diseases

2013

72

Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells

Sanjay Varikuti, Bhawana Singh, Greta Volpedo,

British Journal of Cancer

2020

71

Cutting Edge: CXCR3 Escapes X Chromosome Inactivation in T Cells during Infection: Potential Implications for Sex Differences in Immune Responses

Steve Oghumu, Sanjay Varikuti, James C. Stock,

The Journal of Immunology

2019

52

Cationic solid–lipid nanoparticles are as efficient as electroporation in <scp>DNA</scp> vaccination against visceral leishmaniasis in mice

Noushin Saljoughian, Farnaz Zahedifard, Delaram Doroud,

Parasite Immunology

2013

50

Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis

Hafiz Shoaib Sarwar, Muhammad Sohail, Noushin Saljoughian,

Artificial Cells Nanomedicine and Biotechnology

2018

35

Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis

Mehdi Shahbazi, Farnaz Zahedifard, Noushin Saljoughian,

Veterinary Parasitology

2015

34

The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani

Sanjay Varikuti, Greta Volpedo, Noushin Saljoughian,

The Journal of Infectious Diseases

2018

32

Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana

Sanjay Varikuti, Steve Oghumu, Noushin Saljoughian,

Acta Tropica

2017

23

<i>Leishmania tarentolae</i> expressing <scp>CXCL</scp>‐10 as an efficient immunotherapy approach against <i>Leishmania major</i>‐infected <scp>BALB</scp>/c mice

Hossein Montakhab‐Yeganeh, Zahra Abdossamadi, Farnaz Zahedifard,

Parasite Immunology

2017

23

Page 1